2.3625
price down icon5.50%   -0.1375
after-market Dopo l'orario di chiusura: 2.41 0.0475 +2.01%
loading
Precedente Chiudi:
$2.50
Aprire:
$2.4
Volume 24 ore:
17,468
Relative Volume:
0.01
Capitalizzazione di mercato:
$6.02M
Reddito:
-
Utile/perdita netta:
$-4.74M
Rapporto P/E:
-3.15
EPS:
-0.75
Flusso di cassa netto:
$-3.46M
1 W Prestazione:
-8.78%
1M Prestazione:
-5.88%
6M Prestazione:
-29.67%
1 anno Prestazione:
-56.42%
Intervallo 1D:
Value
$2.2552
$2.4125
Intervallo di 1 settimana:
Value
$2.13
$2.7059
Portata 52W:
Value
$2.0202
$12.00

Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile

Name
Nome
Lipella Pharmaceuticals Inc
Name
Telefono
412-901-0315
Name
Indirizzo
400 N LEXINGTON ST, PITTSBURGH
Name
Dipendente
7
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
LIPO's Discussions on Twitter

Confronta LIPO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
LIPO
Lipella Pharmaceuticals Inc
2.3625 6.02M 0 -4.74M -3.46M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Lipella Pharmaceuticals Inc Borsa (LIPO) Ultime notizie

pulisher
Apr 02, 2025

Virtu Financial LLC Acquires Shares of 13,310 Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast - The Globe and Mail

Mar 31, 2025
pulisher
Mar 31, 2025

Clinical Trial Success: Lipella's 40-Year Veteran Shares Breakthrough Journey in Exclusive Interview - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Lipella Pharmaceuticals Inc. (LIPO) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

LIPELLA PHARMACEUTICALS INC. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 13, 2025

Spartan Capital Securities, LLC Proudly Serves as the Sole Agent in Lipella Pharmaceuticals Inc. - Ukraine Business Journal

Mar 13, 2025
pulisher
Mar 08, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - The Manila Times

Mar 08, 2025
pulisher
Mar 07, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewswire Inc.

Mar 07, 2025
pulisher
Mar 07, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2.21 - Investing.com India

Mar 07, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.'s $3,788,000 Private Placement - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $3,788,000 Private Placement - Yahoo Finance

Mar 04, 2025
pulisher
Mar 02, 2025

Lipella Pharmaceuticals (LIPO) Expected to Announce Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

FDA approves Lipella's oral treatment access program - MSN

Mar 01, 2025
pulisher
Feb 24, 2025

Lipella Pharmaceuticals modifies agreement with Spartan Capital By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Lipella Pharmaceuticals modifies agreement with Spartan Capital - Investing.com

Feb 24, 2025
pulisher
Feb 21, 2025

With New Data, Lipella Plots 2025 Milestones For Oral Rinse Tacrolimus - News & Insights

Feb 21, 2025
pulisher
Feb 17, 2025

Analyzing Lipella Pharmaceuticals (NASDAQ:LIPO) and IDEAYA Biosciences (NASDAQ:IDYA) - Defense World

Feb 17, 2025
pulisher
Feb 13, 2025

Lipella Pharmaceuticals Gains Buy Rating from Jason McCarthy Following Positive Phase 2a Results for LP-310 - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

3 Penny Stocks to Watch Now, 2/13/25 - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Lipella Pharmaceuticals Announces Positive Phase 2a Results for LP-310 in Oral Lichen Planus Treatment - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

Biotech Rips On Topline Analysis - The Globe and Mail

Feb 11, 2025
pulisher
Feb 11, 2025

Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes - AOL.com

Feb 11, 2025
pulisher
Feb 11, 2025

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

Stock market news: Firefly Neuroscience +214.56%, Dominari Holdings +37.66% among top gainers during midday trading - Business Upturn

Feb 11, 2025
pulisher
Feb 11, 2025

Stock market today: Firefly Neuroscience +60.32%, Dominari Holdings +36.36% among top gainers in early trading - Business Upturn

Feb 11, 2025
pulisher
Feb 11, 2025

Lipella Pharmaceuticals Gains FDA Approval for LP-310 - TipRanks

Feb 11, 2025
pulisher
Feb 11, 2025

Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session - Stocks Telegraph

Feb 11, 2025
pulisher
Feb 11, 2025

Clinical Trials News Live Feed - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 11, 2025
pulisher
Feb 11, 2025

How Did Markets React to the Latest Round of Tariff Announcements? - The Globe and Mail

Feb 11, 2025
pulisher
Feb 11, 2025

Clinical Trial Success: Lipella's LP-310 Slashes Pain Scores by 64% in Oral Disease Study - StockTitan

Feb 11, 2025
pulisher
Feb 10, 2025

Top Small Cap Stocks To Watch NowFebruary 06th - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Lipella Pharmaceuticals Inc (LIPO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Taking on analysts’ expectations and winning: Lipella Pharmaceuticals Inc (LIPO) - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Asianet Newsable

Feb 10, 2025
pulisher
Feb 10, 2025

Analyzing the Price-to-Earnings Ratio of Lipella Pharmaceuticals Inc (LIPO) - The News Heater

Feb 10, 2025
pulisher
Feb 09, 2025

🔬 Latest pharma industry updates 👇 - substack.com

Feb 09, 2025
pulisher
Feb 07, 2025

Stock summary: Lipella Pharmaceuticals posted weekly surge of 13.70% as it got FDA approval for an expanded access program - Business Upturn

Feb 07, 2025
pulisher
Feb 07, 2025

LIPO Stock Sees Surge of Approximately 74.16% in Last Five Days - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Is Lipella Pharmaceuticals Inc (NASDAQ:LIPO) stock a better investment at this time? - US Post News

Feb 07, 2025
pulisher
Feb 07, 2025

Lipella Pharmaceuticals Receives Buy Rating Amidst Promising FDA Approval and Strategic Financial Moves - TipRanks

Feb 07, 2025
pulisher
Feb 07, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

Lipella Pharmaceuticals Inc [LIPO] Revenue clocked in at $0.48 million, up 52.46% YTD: What’s Next? - The DBT News

Feb 07, 2025
pulisher
Feb 07, 2025

FDA approves Lipella’s oral treatment access program By Investing.com - Investing.com Nigeria

Feb 07, 2025
pulisher
Feb 06, 2025

Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment - Mugglehead

Feb 06, 2025
pulisher
Feb 06, 2025

United States shares mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com India

Feb 06, 2025
pulisher
Feb 06, 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.28% - Investing.com

Feb 06, 2025
pulisher
Feb 06, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Feb 06, 2025
pulisher
Feb 06, 2025

Offerings News Live Feed - StockTitan

Feb 06, 2025

Lipella Pharmaceuticals Inc Azioni (LIPO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):